1. Aydin, S. E., Kilic, S. S., Aytekin, C., et al. (2015). DOCK8 deficiency: Clinical and immunological phenotype and treatment options – A review of 136 patients. Journal of Clinical Immunology, 35, 189–198.
2. Buckley, R. H. (2001). The hyper-IgE syndrome. Clinical Reviews in Allergy & Immunology, 20, 139–154.
3. Buckley, R. H., Wray, B. B., & Belmaker, E. Z. (1972). Extreme hyperimmunoglobulin E and undue susceptibility to infection. Pediatrics, 49, 59–70.
4. Chamlin, S. L., McCalmont, T. H., Cunningham, B. B., et al. (2002). Cutaneous manifestations of hyper-IgE syndrome in infants and children. Journal of Pediatrics, 141, 572–575.
5. Dau, P. C. (1988). Remission of hyper-IgE treated with plasmapheresis and cytotoxic immunosuppression. Journal of Clinical Apheresis, 4, 8–12.